Article citationsMore>>

Zhang, S., Zhang, J., Wang, C., Chen, X., Zhao, X., Jing, H., Liu, H., Li, Z., Wang, L., Shi, J., Shi, J., et al. (2021) COVID-19 and Ischemic Stroke: Mechanisms of Hypercoagulability (Review). International Journal of Molecular Medicine, 47, Article No. 21.
https://doi.org/10.3892/ijmm.2021.4854

has been cited by the following article:

• TITLE: Laboratory Diagnosis of Bacterial Meningitis in a Patient with COVID-19

  AUTHORS: Irena Ivanova Gencheva-Angelova

  KEYWORDS: Meningitis, Laboratory, Prognosis, CSF, COVID-19

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.9 No.4, April 20, 2021

  ABSTRACT: Against the background of a COVID-19 infection, the overlap of bacterial coinfection is associated with an increased risk of poor treatment outcomes. A 76-year-old man was treated for ischemic stroke in the period of one week. During his hospital stay, he showed symptoms of a viral infection, due to which a PCR sample was taken for SARS-CoV-2. The test result was positive. Meningoencephalitis is suspected on the basis of the clinical symptoms shown and the initial blood test. K. pneumonia was detected by a cerebrospinal fluid (CSF) microbiological examination. The risk of bacterial coinfection with COVID-19 remains unclear. Timely and rapid diagnosis and treatment of bacterial meningitis, in the context of a proven COVID-19 infection, require a variety of biological tests and a multidisciplinary approach. In the early stages of acute bacterial and viral meningitis, the signs and symptoms are often nonspecific and it is not always possible to make a differential diagnosis. Laboratory tests, characterizing COVID-19, should determine the type, prognosis, and outcome of a bacterial coinfection. Refining the laboratory diagnosis of a bacterial infection with COVID-19 is a new challenge for doctors.